Compare Exelixis Inc. Common Stock (EXEL) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs RLX Technology Inc — how do they compare? Exelixis Inc. Common Stock trades at $59.77 (market cap $14.62B), while RLX Technology Inc trades at $1.73 (market cap $2.10B). The key difference: Exelixis Inc. Common Stock is far larger — about 7× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.81% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and RLX Technology Inc for 35 Days on average.
| EXEL | RLX | |
|---|---|---|
Market Cap | $14.62B | $2.10B |
Volume | 2,684,957 | 1,079,706 |
Sector | Health | Consumer Staples |
52-Week High | $59.13 | $2.57 |
52-Week Low | $34.54 | $1.68 |
Typical Hold Time | 1 Days | 35 Days |
Enterprise Value | $13.95B | $832.26M |
Dividend Yield | — | 5.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RLX Technology trades at $1.735, up 0.29% with bearish technical signals despite recent 52-week lows. The company shows solid fundamentals with $3.62B revenue, 21.87% net margin, and attractive valuation at P/E 15.46 and P/B 0.91. Recent earnings missed expectations but international expansion drives growth, with 70% revenue now from overseas markets. Cash flow trends improved significantly from -$99M in 2025 to $881M projected for 2026.
RLX presents a value opportunity with discounted valuation and strong international growth, though technical weakness and earnings misses warrant caution. The single analyst coverage maintains Hold rating, reflecting uncertainty amid expansion execution risks and regulatory challenges in the e-vapor industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
